Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Chronic Obstructive Pulmonary Disease Drugs Market : detailed segmentation and forecast

Wednesday, November 9, 2016 1:55
% of readers think this story is Fact. Add your two cents.

(Before It's News)

bigmarketresearch.com include new market research report ”Global Chronic Obstructive Pulmonary Disease Drugs Market 2016-2020”

About Chronic Obstructive Pulmonary Disease (COPD)

COPD is a chronic disease condition with a combination of symptoms of both chronic bronchitis and emphysema. Chronic bronchitis results in inflammation in the bronchioles, which results in increased mucus production. The condition is usually associated with a long-term cough with mucus. Emphysema results in the destruction of the walls of the alveoli, resulting in difficulty in breathing. Analysts forecast the global chronic obstructive pulmonary disease (COPD) drugs market to grow at a CAGR of 4.85% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global chronic obstructive pulmonary disease (COPD) drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used to treat COPD.

Acquire sample copy here @ http://www.bigmarketresearch.com/request-sample/629261

The market is divided into the following segments based on geography:

• Americas

• APAC

• EMEA

Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

• AstraZeneca

• Boehringer Ingelheim

• GSK

• Merck

• Novartis

• Teva

Request for discount here @ http://www.bigmarketresearch.com/purchase-enquiry/629261

Other prominent vendors

• Prosonix

• Pulmagen Therapeutics

• RespiVert

• SolAeroMed

• Sunovion Pharmaceuticals

• Theravance Biopharma

• Theron Pharmaceuticals

Market driver

• Uptake of LABA/LAMA combination therapies

• For a full, detailed list, view our report

Market challenge

• Negligence toward use of controller medications

• For a full, detailed list, view our report

Market trend

• Increased adoption of e-cigarettes and smoking cessation products

• For a full, detailed list, view our report

About Company :

Big Market Research uniqueness lies in its highly ethical reports at economical rates because we value your relationship and growth more than money. Your growth is our aim. With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

Contact Us :

Dhananjay Potle

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Direct :+ 1-503-894-6022

Toll Free :  + 1-800-910-6452

Email: help@bigmarketresearch.com

Web: http://www.bigmarketresearch.com

 

 

 

 

 

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.